TipRanks
Geratherm Medical AG (DE:GME)
XETRA:GME
Germany Market
GME
Geratherm Medical
RESEARCH TOOLSreports
Want to see DE:GME full AI Analyst Report?

Geratherm Medical (GME) Ratios

10 Followers

Geratherm Medical Ratios

DE:GME's free cash flow for Q2 2026 was €0.70. For the 2026 fiscal year, DE:GME's free cash flow was decreased by € and operating cash flow was €-0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 11.70 6.41 5.21 2.93 10.67
Quick Ratio
 8.67 4.99 3.55 1.61 7.13
Cash Ratio
 4.98 2.97 2.16 0.74 4.00
Solvency Ratio
 0.04 0.05 0.33 0.22 0.15
Operating Cash Flow Ratio
 0.45 0.54 0.53 0.20 1.19
Short-Term Operating Cash Flow Coverage
 0.00 0.86 1.15 0.00 0.00
Net Current Asset Value
€ 9.47M€ 9.85M€ 10.81M€ 7.78M€ 7.16M
Leverage Ratios
Debt-to-Assets Ratio
 0.09 0.10 0.11 0.20 0.24
Debt-to-Equity Ratio
 0.11 0.13 0.16 0.32 0.42
Debt-to-Capital Ratio
 0.10 0.11 0.13 0.24 0.29
Long-Term Debt-to-Capital Ratio
 0.10 0.11 0.07 0.24 0.29
Financial Leverage Ratio
 1.32 1.32 1.36 1.60 1.72
Debt Service Coverage Ratio
 0.00 -0.04 1.53 23.15 15.26
Interest Coverage Ratio
 0.00 -16.89 16.27 11.09 7.73
Debt to Market Cap
 0.19 0.26 0.17 0.25 0.34
Interest Debt Per Share
 0.36 0.47 0.63 1.36 1.74
Net Debt to EBITDA
 -21.42 33.19 -1.49 0.48 0.17
Profitability Margins
Gross Profit Margin
66.77%15.95%62.59%29.93%24.68%
EBIT Margin
-6.24%-8.84%5.34%11.82%7.33%
EBITDA Margin
1.48%-1.04%14.44%19.97%13.04%
Operating Profit Margin
13.96%-8.84%8.63%8.09%5.36%
Pretax Profit Margin
-6.93%-6.10%4.81%11.03%6.63%
Net Profit Margin
-5.81%-5.51%3.45%5.30%3.96%
Continuous Operations Profit Margin
-6.94%-5.57%3.20%7.95%4.19%
Net Income Per EBT
83.84%90.30%71.81%48.09%59.71%
EBT Per EBIT
-49.63%69.05%55.68%136.23%123.60%
Return on Assets (ROA)
-3.34%-3.15%2.47%3.11%2.67%
Return on Equity (ROE)
-4.38%-4.17%3.35%4.98%4.58%
Return on Capital Employed (ROCE)
8.49%-5.61%7.06%5.93%3.83%
Return on Invested Capital (ROIC)
8.49%-4.79%4.50%4.27%2.42%
Return on Tangible Assets
-3.58%-3.38%2.62%3.57%3.00%
Earnings Yield
-6.32%-5.24%3.74%3.80%3.77%
Efficiency Ratios
Receivables Turnover
 10.31 11.75 15.35 12.51 8.68
Payables Turnover
 7.18 18.76 9.54 17.34 12.87
Inventory Turnover
 1.17 3.44 1.30 1.56 2.51
Fixed Asset Turnover
 2.21 2.13 2.66 2.22 2.59
Asset Turnover
 0.58 0.57 0.72 0.59 0.67
Working Capital Turnover Ratio
 1.00 1.03 1.42 1.20 1.60
Cash Conversion Cycle
 296.14 117.76 267.30 241.57 158.83
Days of Sales Outstanding
 35.40 31.06 23.78 29.19 42.06
Days of Inventory Outstanding
 311.55 106.16 281.79 233.44 145.13
Days of Payables Outstanding
 50.81 19.45 38.27 21.05 28.36
Operating Cycle
 346.95 137.21 305.57 262.63 187.19
Cash Flow Ratios
Operating Cash Flow Per Share
 0.10 0.26 0.34 0.26 0.48
Free Cash Flow Per Share
 0.07 0.23 0.23 -0.04 -0.02
CapEx Per Share
 0.03 0.03 0.12 0.30 0.50
Free Cash Flow to Operating Cash Flow
 0.68 0.88 0.66 -0.15 -0.05
Dividend Paid and CapEx Coverage Ratio
 0.84 1.97 1.58 0.58 0.77
Capital Expenditure Coverage Ratio
 3.11 8.56 2.91 0.87 0.95
Operating Cash Flow Coverage Ratio
 0.28 0.56 0.57 0.20 0.28
Operating Cash Flow to Sales Ratio
 0.04 0.09 0.09 0.07 0.10
Free Cash Flow Yield
3.50%7.83%6.51%-0.73%-0.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -15.47 -19.27 26.77 26.30 26.55
Price-to-Sales (P/S) Ratio
 0.80 1.05 0.92 1.39 1.05
Price-to-Book (P/B) Ratio
 0.68 0.80 0.90 1.31 1.22
Price-to-Free Cash Flow (P/FCF) Ratio
 27.90 12.78 15.36 -137.85 -204.29
Price-to-Operating Cash Flow Ratio
 21.39 11.28 10.09 20.42 10.43
Price-to-Earnings Growth (PEG) Ratio
 0.10 0.09 -0.70 2.50 0.04
Price-to-Fair Value
 0.68 0.80 0.90 1.31 1.22
Enterprise Value Multiple
 32.32 -67.97 4.90 7.46 8.23
Enterprise Value
 7.30M 10.51M 14.43M 31.22M 27.73M
EV to EBITDA
 33.57 -67.97 4.90 7.46 8.23
EV to Sales
 0.50 0.71 0.71 1.49 1.07
EV to Free Cash Flow
 17.43 8.59 11.77 -147.25 -208.48
EV to Operating Cash Flow
 11.81 7.58 7.73 21.82 10.64
Tangible Book Value Per Share
 2.81 3.27 3.55 3.32 3.29
Shareholders’ Equity Per Share
 3.17 3.63 3.88 4.13 4.10
Tax and Other Ratios
Effective Tax Rate
 -0.16 0.09 0.32 0.28 0.37
Revenue Per Share
 2.40 2.75 3.77 3.87 4.75
Net Income Per Share
 -0.14 -0.15 0.13 0.21 0.19
Tax Burden
 0.84 0.90 0.72 0.48 0.60
Interest Burden
 1.11 0.69 0.90 0.93 0.91
Research & Development to Revenue
 0.12 0.09 0.00 0.07 0.05
SG&A to Revenue
 0.41 0.16 0.16 0.15 0.13
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -0.72 -1.69 2.85 1.29 2.55
Currency in EUR